Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Blood Transfusion Ameliorates Free Haem-Induced Loss of Thrombomodulin and Endothelial Cell Activation in Paediatric Sickle Cell Anaemia

Helen Fogarty, Soracha Ward, Ellie Karampini, Azaz Ahmad, Gemma Leon, Aisling Rehill, Rosena Geoghegan, Helena Conroy, Noel Ngwenya, Mary Byrne, Ulrich Budde, Sonja Schneppenheim, Emma Tuohy, Corrina McMahon, James O'Donnell

Blood (2022) 140 (Supplement 1): 5373–5374.

https://doi.org/10.1182/blood-2022-157962

Published: 2022

Journal Articles

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Michelle Lavin, Sonia Aguila, Sonja Schneppenheim, Niall Dalton, Kenneth L. Jones, Jamie M. O’Sullivan, Niamh M. O’Connell, Kevin Ryan, Barry White, Mary Byrne, Marie Rafferty, Mairead M. Doyle, Margaret Nolan, Roger J. S. Preston, Ulrich Budde, Paula James, Jorge Di Paola, James S. O’Donnell

Blood (2017) 130 (21): 2344–2353.

https://doi.org/10.1182/blood-2017-05-786699

Published: 2017

Includes: Supplemental data

Journal Articles

First-in-Man Emergency Use of Plasminogen Replacement for Respiratory Failure Due to Congenital Hypoplasminogenemia

Wolf A Hassenpflug, MD, John Moran, MD, Johanna Schrum, MD, Sarah Müller-Stöver, MD, Sonja Schneppenheim, MD, Reinhard Schneppenheim

Blood (2016) 128 (22): 3792.

https://doi.org/10.1182/blood.V128.22.3792.3792

Published: 2016

Journal Articles

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Michelle Lavin, MB FRCPath, Sonia Aguila, PhD, Sonja Schneppenheim, MD, Niall Dalton, BSc, Jamie M O'Sullivan, PhD, Niamh M O'Connell, MB, FRCPath, PhD, Kevin M. Ryan, MB, Mary Byrne, MSc, Margaret Nolan, BSc, Roger Preston, PhD, Ulrich Budde, MD, Paula D. James, MD, Jorge Di Paola, MD, James S O'Donnell, MD PhD

Blood (2016) 128 (22): 873.

https://doi.org/10.1182/blood.V128.22.873.873

Published: 2016

Journal Articles

von Willebrand factor is dimerized by protein disulfide isomerase

Svenja Lippok, Katra Kolšek, Achim Löf, Dennis Eggert, Willem Vanderlinden, Jochen P. Müller, Gesa König, Tobias Obser, Karoline Röhrs, Sonja Schneppenheim, Ulrich Budde, Carsten Baldauf, Camilo Aponte-Santamaría, Frauke Gräter, Reinhard Schneppenheim, Joachim O. Rädler, Maria A. Brehm

Blood (2016) 127 (9): 1183–1191.

https://doi.org/10.1182/blood-2015-04-641902

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

The Acquired Von Willebrand Syndrome in Patients with Monoclonal IgA Proteins Is Rare but May be Clinically Severe

Ulrich Budde, MD, Rita Dittmer, MD, Sonja Schneppenheim, MD, Tina Rausch

Blood (2014) 124 (21): 2830.

https://doi.org/10.1182/blood.V124.21.2830.2830

Published: 2014

Journal Articles

Spectrum Of The Acquired Von Willebrand Syndrome In a Large Cohort Of Patients Diagnosed In a Single Institution

Ulrich Budde, MD, Rita Dittmer, Hala El- Abd Müller, Hanna Schaeper, Sonja Schneppenheim, MD

Blood (2013) 122 (21): 3607.

https://doi.org/10.1182/blood.V122.21.3607.3607

Published: 2013

Journal Articles

Subcellular Localization of Von Willebrand Factor Mutants Correlates with Particular VWF Multimer Patterns

Maria A. Brehm, PhD, Tobias Obser, Ulrich Budde, MD, Sonja Schneppenheim, MD, Reinhard Schneppenheim, MD, PhD

Blood (2012) 120 (21): 98.

https://doi.org/10.1182/blood.V120.21.98.98

Published: 2012

Journal Articles

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Reinhard Schneppenheim, MD, PhD, Ulrich Budde, MD, Javier Batlle, MD, Giancarlo Castaman, MD, Jeroen C. J. Eikenboom, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Tobias Obser, Florian Oyen, Francesco Rodeghiero, MD, Sonja Schneppenheim, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2012) 120 (21): 99.

https://doi.org/10.1182/blood.V120.21.99.99

Published: 2012

Journal Articles

A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE

Reinhard Schneppenheim, Jan Jacques Michiels, Tobias Obser, Florian Oyen, Antje Pieconka, Sonja Schneppenheim, Kerstin Will, Barbara Zieger, Ulrich Budde

Blood (2010) 115 (23): 4894–4901.

https://doi.org/10.1182/blood-2009-07-226324

Published: 2010

Journal Articles

The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF

Sandra L. Haberichter, Ulrich Budde, Tobias Obser, Sonja Schneppenheim, Cornelia Wermes, Reinhard Schneppenheim

Blood (2010) 115 (22): 4580–4587.

https://doi.org/10.1182/blood-2009-09-244327

Published: 2010

Includes: Supplemental data

Journal Articles

Force Dependent Structural Changes of the Von Willebrand Factor A2 Domain Are Required for VWF Cleavage by ADAMTS13

Reinhard Schneppenheim, MD, PhD, Carsten Baldauf, PhD, Tobias Obser, Ulrich Budde, MD, Antje Pieconka, Sonja Schneppenheim, MD, Frauke Graeter, PhD

Blood (2008) 112 (11): 589.

https://doi.org/10.1182/blood.V112.11.589.589

Published: 2008

Journal Articles

Molecular Background of “Smeary” von Willebrand Factor Multimers.

Reinhard Schneppenheim, MD, PhD, Olivier Marggraf, Heike Eckert, Tobias Obser, Florian Oyen, Antje Pieconka, Sonja Schneppenheim, MD, Kerstin Will, Ulrich Budde, MD

Blood (2007) 110 (11): 2711.

https://doi.org/10.1182/blood.V110.11.2711.2711

Published: 2007

Journal Articles

Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis

Wolf Achim Hassenpflug, Ulrich Budde, Tobias Obser, Dorothea Angerhaus, Elke Drewke, Sonja Schneppenheim, Reinhard Schneppenheim

Blood (2006) 107 (6): 2339–2345.

https://doi.org/10.1182/blood-2005-04-1758

Published: 2006

Journal Articles

The Impact of Mutations in the A2 Domain of Von Willebrand Factor on its Cleavage by ADAMTS13.

Wolf A. Hassenpflug, M.D., Ulrich Budde, M.D., Tobias Obser, Dorothea Angerhaus, Elke Drewke, Sonja Schneppenheim, Reinhard Schneppenheim, Ph.D. M.D.

Blood (2004) 104 (11): 3666.

https://doi.org/10.1182/blood.V104.11.3666.3666

Published: 2004

Journal Articles

Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease

Reinhard Schneppenheim, Ulrich Budde, Tobias Obser, Jacqueline Brassard, Kerstin Mainusch, Zaverio M. Ruggeri, Sonja Schneppenheim, Rainer Schwaab, Johannes Oldenburg

Blood (2001) 97 (7): 2059–2066.

https://doi.org/10.1182/blood.V97.7.2059

Published: 2001

NARROW

Blood Transfusion Ameliorates Free Haem-Induced Loss of Thrombomodulin and Endothelial Cell Activation in Paediatric Sickle Cell Anaemia

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

First-in-Man Emergency Use of Plasminogen Replacement for Respiratory Failure Due to Congenital Hypoplasminogenemia

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

von Willebrand factor is dimerized by protein disulfide isomerase

The Acquired Von Willebrand Syndrome in Patients with Monoclonal IgA Proteins Is Rare but May be Clinically Severe

Spectrum Of The Acquired Von Willebrand Syndrome In a Large Cohort Of Patients Diagnosed In a Single Institution

Subcellular Localization of Von Willebrand Factor Mutants Correlates with Particular VWF Multimer Patterns

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE

The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF

Force Dependent Structural Changes of the Von Willebrand Factor A2 Domain Are Required for VWF Cleavage by ADAMTS13

Molecular Background of “Smeary” von Willebrand Factor Multimers.

Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis

The Impact of Mutations in the A2 Domain of Von Willebrand Factor on its Cleavage by ADAMTS13.

Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only